These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20828724)

  • 21. Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series.
    Viale G; Rotmensz N; Maisonneuve P; Orvieto E; Maiorano E; Galimberti V; Luini A; Colleoni M; Goldhirsch A; Coates AS
    Breast Cancer Res Treat; 2009 Sep; 117(1):211-4. PubMed ID: 18629634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis.
    Chen SL; Hoehne FM; Giuliano AE
    Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival analysis between patients with invasive ductal and invasive lobular breast cancer.
    Dian D; Herold H; Mylonas I; Scholz C; Janni W; Sommer H; Friese K
    Arch Gynecol Obstet; 2009 Jan; 279(1):23-8. PubMed ID: 18449551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
    Bharat A; Gao F; Margenthaler JA
    Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer.
    Philippin-Lauridant G; Baranzelli MC; Samson C; Fournier C; Pinte S; Mattot V; Bonneterre J; Soncin F
    Int J Oncol; 2013 Apr; 42(4):1367-75. PubMed ID: 23404186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
    Falco M
    Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationship.
    Purushotham A; Shamil E; Cariati M; Agbaje O; Muhidin A; Gillett C; Mera A; Sivanadiyan K; Harries M; Sullivan R; Pinder SE; Garmo H; Holmberg L
    Eur J Cancer; 2014 Jul; 50(10):1697-1705. PubMed ID: 24768572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perineural invasion has no prognostic value in patients with invasive breast carcinoma.
    Duraker N; Caynak ZC; Türköz K
    Breast; 2006 Oct; 15(5):629-34. PubMed ID: 16466917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
    Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI
    Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A comparative study of metastatic patterns of ductal and lobular carcinoma of the breast from two matched series (376 patients)].
    Fondrinier E; Guérin O; Lorimier G
    Bull Cancer; 1997 Dec; 84(12):1101-7. PubMed ID: 9587361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
    Sullivan PS; Apple SK
    Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD24 expression has a prognostic impact in breast carcinoma.
    Athanassiadou P; Grapsa D; Gonidi M; Athanassiadou AM; Tsipis A; Patsouris E
    Pathol Res Pract; 2009; 205(8):524-33. PubMed ID: 19243896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.
    Liu F; Cui L; Zhang Y; Chen L; Wang Y; Fan Y; Lei T; Gu F; Lang R; Pringle GA; Zhang X; Chen Z; Fu L
    Breast Cancer Res Treat; 2010 Dec; 124(3):677-88. PubMed ID: 20213083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer.
    Schoppmann SF; Berghoff A; Dinhof C; Jakesz R; Gnant M; Dubsky P; Jesch B; Heinzl H; Birner P
    Breast Cancer Res Treat; 2012 Jul; 134(1):237-44. PubMed ID: 22350732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Younger women with breast carcinoma have a poorer prognosis than older women.
    Chung M; Chang HR; Bland KI; Wanebo HJ
    Cancer; 1996 Jan; 77(1):97-103. PubMed ID: 8630946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast.
    Warneke J; Berger R; Johnson C; Stea D; Villar H
    Am J Surg; 1996 Nov; 172(5):496-500. PubMed ID: 8942552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression.
    Demir H; Turna H; Can G; Ilvan S
    J BUON; 2010; 15(4):774-82. PubMed ID: 21229645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The labelling index as a prognostic marker in breast carcinoma].
    Bisail M; Nieddu S; Sarobba MG; Sanna G; Milia V; Ghì MG; Farris A
    Minerva Med; 1994 Apr; 85(4):141-4. PubMed ID: 8028740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.